CRL vs MOH: Which Stock Is the Better Buy?
Charles River Laboratories International, Inc. and Molina Healthcare, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CRL vs MOH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Charles River Laboratories International, Inc. (CRL) | Molina Healthcare, Inc. (MOH) | |
|---|---|---|
| Market cap | $10.8B | $10.3B |
| Revenue (latest FY) | $4.02B | $45.43B |
| Net income (latest FY) | $-144.34M | $472.00M |
| Revenue growth (5y CAGR) | 6.5% | 18.5% |
| Net margin | -3.6% | 1.0% |
| Return on equity | -4.6% | 11.6% |
| P/E ratio | — | 52.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 9 | 9 |
| Positive free cash flow | Yes | No |
See the full CRL vs MOH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CRL's full financials → Open MOH's full financials →More comparisons
Frequently asked questions
Which is bigger, CRL or MOH?
Charles River Laboratories International, Inc. is larger by market capitalization — $10.8B versus $10.3B.
Which grows faster, CRL or MOH?
Over the last five fiscal years, Molina Healthcare, Inc. grew revenue faster — 18.5%/yr versus 6.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CRL fundamentals → · MOH fundamentals → · All 1,500+ companies → · Free screener →